The Fate of Transplanted Olfactory Progenitors Is Conditioned by the Cell Phenotypes of the Receiver Brain Tissue in Cocultures.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
30 09 2020
Historique:
received: 05 08 2020
revised: 13 09 2020
accepted: 25 09 2020
entrez: 3 10 2020
pubmed: 4 10 2020
medline: 24 2 2021
Statut: epublish

Résumé

Among the numerous candidates for cell therapy of the central nervous system (CNS), olfactory progenitors (OPs) represent an interesting alternative because they are free of ethical concerns, are easy to collect, and allow autologous transplantation. In the present study, we focused on the optimization of neuron production and maturation. It is known that plated OPs respond to various trophic factors, and we also showed that the use of Nerve Growth Factor (NGF) allowed switching from a 60/40 neuron/glia ratio to an 80/20 one. Nevertheless, in order to focus on the integration of OPs in mature neural circuits, we cocultured OPs in primary cultures obtained from the cortex and hippocampus of newborn mice. When dissociated OPs were plated, they differentiated into both glial and neuronal phenotypes, but we obtained a 1.5-fold higher viability in cortex/OP cocultures than in hippocampus/OP ones. The fate of OPs in cocultures was characterized with different markers such as BrdU, Map-2, and Synapsin, indicating a healthy integration. These results suggest that the integration of transplanted OPs might by affected by trophic factors and the environmental conditions/cell phenotypes of the host tissue. Thus, a model of coculture could provide useful information on key cell events for the use of progenitors in cell therapy.

Identifiants

pubmed: 33008128
pii: ijms21197249
doi: 10.3390/ijms21197249
pmc: PMC7582579
pii:
doi:

Substances chimiques

Nerve Growth Factor 9061-61-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Science. 2000 Dec 1;290(5497):1775-9
pubmed: 11099418
Brain Res Bull. 2005 Dec 15;68(1-2):83-94
pubmed: 16325008
J Neurosci Res. 2006 Dec;84(8):1630-44
pubmed: 17044030
Stem Cell Res. 2015 Jul;15(1):23-9
pubmed: 25965912
Stem Cells. 2005 Mar;23(3):442-53
pubmed: 15749939
Genes Dev. 2017 Oct 15;31(20):2023-2038
pubmed: 29138279
Neurobiol Dis. 2005 Oct;20(1):38-48
pubmed: 16137565
Brain. 2005 Dec;128(Pt 12):2951-60
pubmed: 16219671
Int J Hematol. 2004 Jan;79(1):7-14
pubmed: 14979472
Neuroscience. 1999 Jan;88(2):571-83
pubmed: 10197776
Neurobiol Dis. 2007 May;26(2):363-74
pubmed: 17346980
Eur J Neurosci. 2005 Oct;22(7):1581-8
pubmed: 16197498
Transplant Proc. 2004 Oct;36(8):2504-6
pubmed: 15561296
Stem Cells. 2006 Feb;24(2):434-42
pubmed: 16141360
Neurodegener Dis. 2006;3(1-2):19-26
pubmed: 16909032
J Spinal Cord Med. 2006;29(3):191-203; discussion 204-6
pubmed: 16859223
Exp Neurol. 2004 Dec;190(2):276-88
pubmed: 15530869
Methods Mol Biol. 2019;1938:3-18
pubmed: 30617969
J Clin Invest. 2018 Jan 2;128(1):463-482
pubmed: 29227284
Brain Res. 2006 Feb 16;1073-1074:109-19
pubmed: 16455065
Neurobiol Dis. 2006 Mar;21(3):587-606
pubmed: 16256357
Exp Hematol. 2006 Jul;34(7):914-25
pubmed: 16797419
Stem Cell Res. 2013 Nov;11(3):1178-90
pubmed: 24012985
Brain. 2002 Jan;125(Pt 1):14-21
pubmed: 11834589
Histol Histopathol. 2006 Jun;21(6):633-43
pubmed: 16528674
Nat Neurosci. 2017 Apr 25;20(5):637-647
pubmed: 28440805
Brain Res Bull. 2006 Oct 16;70(4-6):457-66
pubmed: 17027782
Stem Cells Dev. 2006 Jun;15(3):407-21
pubmed: 16846377
Exp Neurol. 2003 Dec;184(2):615-35
pubmed: 14769354
Mol Cell Neurosci. 2001 Mar;17(3):561-76
pubmed: 11273650
Biotech Histochem. 2005 Sep-Dec;80(5-6):189-200
pubmed: 16720519
Front Neurosci. 2019 Apr 18;13:361
pubmed: 31057356
Nat Commun. 2018 Jan 8;9(1):84
pubmed: 29311559
J Neurosci. 2004 Jun 23;24(25):5670-83
pubmed: 15215289
Exp Neurol. 2011 Jun;229(2):308-23
pubmed: 21376038
Neuroscience. 2000;99(2):343-50
pubmed: 10938440
Neurochem Int. 2017 Sep;108:417-425
pubmed: 28600187
Science. 2000 Dec 1;290(5497):1779-82
pubmed: 11099419
J Pharmacol Sci. 2011;115(4):425-32
pubmed: 21422724
J Med Invest. 2006 Feb;53(1-2):42-51
pubmed: 16537995
Exp Neurol. 2006 Oct;201(2):281-92
pubmed: 16904107
Mol Neurobiol. 2018 Mar;55(3):2516-2523
pubmed: 28391555
J Clin Invest. 2018 Jan 2;128(1):116-119
pubmed: 29227287
Exp Neurol. 2004 Apr;186(2):112-23
pubmed: 15026250
Eur J Neurosci. 2006 Apr;23(8):2119-34
pubmed: 16630059
Dev Dyn. 2005 Jun;233(2):496-515
pubmed: 15782416
Neuroscience. 2017 Jul 4;355:84-100
pubmed: 28499977
Am J Rhinol. 2005 Jan-Feb;19(1):83-90
pubmed: 15794081
J Cell Physiol. 2015 Jan;230(1):116-30
pubmed: 24911171
Regen Med. 2017 Oct;12(7):839-851
pubmed: 29119870
Curr Neurovasc Res. 2004 Jul;1(3):207-13
pubmed: 16181071
Exp Neurol. 2005 Jul;194(1):12-30
pubmed: 15899240
Brain Res Dev Brain Res. 2004 Oct 15;153(1):39-51
pubmed: 15464216
J Med Ethics. 2004 Aug;30(4):410-3
pubmed: 15289540
Microsc Res Tech. 2002 Aug 1;58(3):176-88
pubmed: 12203696
Exp Dermatol. 2006 Oct;15(10):794-800
pubmed: 16984261
Glia. 2007 Mar;55(4):385-99
pubmed: 17152062
Stem Cell Reports. 2017 Jun 6;8(6):1727-1742
pubmed: 28591653
Exp Neurol. 2005 Jun;193(2):312-25
pubmed: 15869934

Auteurs

Grégory Pourié (G)

Inserm UMR1256/NGERE, Faculté de Medecine, 9 Avenue de la Forêt de Haye, Université de Lorraine, F-54000 Nancy, France.
Laboratoire de Neurosciences, Place Leclerc, Université de Franche-Comté, F-25000 Besancon, France.

Nassila Akchiche (N)

Inserm UMR1256/NGERE, Faculté de Medecine, 9 Avenue de la Forêt de Haye, Université de Lorraine, F-54000 Nancy, France.

Jean-Louis Millot (JL)

Laboratoire de Neurosciences, Place Leclerc, Université de Franche-Comté, F-25000 Besancon, France.

Jean-Louis Guéant (JL)

Inserm UMR1256/NGERE, Faculté de Medecine, 9 Avenue de la Forêt de Haye, Université de Lorraine, F-54000 Nancy, France.

Jean-Luc Daval (JL)

Inserm UMR1256/NGERE, Faculté de Medecine, 9 Avenue de la Forêt de Haye, Université de Lorraine, F-54000 Nancy, France.

Carine Bossenmeyer-Pourié (C)

Inserm UMR1256/NGERE, Faculté de Medecine, 9 Avenue de la Forêt de Haye, Université de Lorraine, F-54000 Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH